Identification	O
of	O
a	O
novel	O
cell	O
type	O
-	O
specific	O
intronic	O
enhancer	O
of	O
macrophage	O
migration	O
inhibitory	O
factor	O
(	O
MIF	O
)	O
and	O
its	O
regulation	O
by	O
mithramycin	O
.	O


The	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
genetic	O
regulation	O
of	O
macrophage	O
migration	O
inhibitory	O
factor	O
(	O
MIF	O
)	O
.	O


DNase	O
I	O
hypersensitivity	O
was	O
used	O
to	O
identify	O
potential	O
hypersensitive	O
sites	O
(	O
HS	O
)	O
across	O
the	O
MIF	O
gene	O
locus	O
.	O


Reporter	O
gene	O
assays	O
were	O
performed	O
in	O
different	O
human	O
cell	O
lines	O
with	O
constructs	O
containing	O
the	O
native	O
or	O
mutated	O
HS	O
element	O
.	O


Following	O
phylogenetic	O
and	O
transcription	O
factor	O
binding	O
profiling	O
,	O
electrophoretic	O
mobility	O
shift	O
assay	O
(	O
EMSA	O
)	O
and	O
RNA	O
interference	O
were	O
performed	O
and	O
the	O
effects	O
of	O
incubation	O
with	O
mithramycin	O
,	O
an	O
antibiotic	O
that	O
binds	O
GC	O
boxes	O
,	O
were	O
also	O
studied	O
.	O


An	O
HS	O
centred	O
on	O
the	O
first	O
intron	O
of	O
MIF	O
was	O
identified	O
.	O


The	O
HS	O
acted	O
as	O
an	O
enhancer	O
in	O
human	B-TISSUE
T	I-TISSUE
lymphoblasts	E-TISSUE
(	O
CEMC7A	S-TISSUE
)	O
,	O
human	B-TISSUE
embryonic	I-TISSUE
kidney	I-TISSUE
cells	E-TISSUE
(	O
HEK293T	S-TISSUE
)	O
and	O
human	B-TISSUE
monocytic	I-TISSUE
cells	E-TISSUE
(	O
THP	B-TISSUE
-	I-TISSUE
1	E-TISSUE
)	O
,	O
but	O
not	O
in	O
a	O
fibroblast	B-TISSUE
-	I-TISSUE
like	I-TISSUE
synoviocyte	I-TISSUE
(	I-TISSUE
FLS	I-TISSUE
)	I-TISSUE
cell	I-TISSUE
line	E-TISSUE
(	O
SW982	S-TISSUE
)	O
or	O
cultured	B-TISSUE
FLS	I-TISSUE
derived	I-TISSUE
from	I-TISSUE
rheumatoid	I-TISSUE
arthritis	I-TISSUE
(	I-TISSUE
RA	I-TISSUE
)	I-TISSUE
patients	E-TISSUE
.	O


Two	O
cis	O
-	O
elements	O
within	O
the	O
first	O
intron	O
were	O
found	O
to	O
be	O
responsible	O
for	O
the	O
enhancer	O
activity	O
.	O


Mutation	O
of	O
the	O
consensus	O
Sp1	O
GC	O
box	O
on	O
each	O
cis	O
-	O
element	O
abrogated	O
enhancer	O
activity	O
and	O
EMSA	O
indicated	O
Sp1	O
binding	O
to	O
one	O
of	O
the	O
cis	O
-	O
elements	O
contained	O
in	O
the	O
intron	O
.	O


SiRNA	O
knock	O
-	O
down	O
of	O
Sp1	O
alone	O
or	O
Sp1	O
and	O
Sp3	O
together	O
was	O
incomplete	O
and	O
did	O
not	O
alter	O
the	O
enhancer	O
activity	O
.	O


Mithramycin	O
inhibited	O
expression	O
of	O
MIF	O
in	O
CEMC7A	S-TISSUE
cells	O
.	O


This	O
effect	O
was	O
specific	O
to	O
the	O
intronic	O
enhancer	O
and	O
was	O
not	O
seen	O
on	O
the	O
MIF	O
promoter	O
.	O


These	O
results	O
identify	O
a	O
novel	O
,	O
cell	O
type	O
-	O
specific	O
enhancer	O
of	O
MIF	O
.	O


The	O
enhancer	O
appears	O
to	O
be	O
driven	O
by	O
Sp1	O
or	O
related	O
Sp	O
family	O
members	O
and	O
is	O
highly	O
sensitive	O
to	O
inhibition	O
via	O
mithramycin	O
.	O
